Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson’s disease

Journal of Neurology

Volumn 263, Issue 6, 2016, Pages 1178-1187

  Xu, Yaqian ^a   Yang, Jing ^a   Hu, Xinyu ^a   Shang, Huifang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Gray matter volume; Meta analysis; Parkinson s disease dementia (PDD); Parkinson s disease with mild cognitive impairment (PD MCI); Signed differential mapping; Voxel based morphometry

Indexed keywords

BRAIN; COGNITIVE DYSFUNCTION; COMPLICATION; DIAGNOSTIC IMAGING; GRAY MATTER; HUMAN; META ANALYSIS; NEUROIMAGING; ORGAN SIZE; PARKINSON DISEASE; PATHOLOGY; PSYCHOLOGY;

BRAIN; COGNITIVE DYSFUNCTION; GRAY MATTER; HUMANS; NEUROIMAGING; ORGAN SIZE; PARKINSON DISEASE;

EID: 84964474404     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-016-8122-3     Document Type: Article

References (52)

1. Schapira AH (2015) The measurement and importance of non-motor symptoms in Parkinson disease. Eur J Neurol 22(1):2–3. doi:10.1111/ene.12523
2. Lee JE, Cho KH, Song SK, Kim HJ, Lee HS, Sohn YH, Lee PH (2014) Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry 85 (1):7-16. doi:10.1136/jnnp-2013-305062
3. Petrou M, Kotagal V, Bohnen NI (2012) An update on brain imaging in parkinsonian dementia. Imaging Med 4(2):201–213. doi:10.2217/iim.12.10
4. Hu XF, Zhang JQ, Zhang YL, Wu Y, Chen LH, Wang J (2013) Mild cognitive impairment in patients with Parkinson's disease: A voxel-based morphometry analysis of gray matter. [Chinese]. Chinese Journal of Medical Imaging Technology 29 (1):24-29
5. Green J, McDonald WM, Vitek JL, Evatt M, Freeman A, Haber M, Bakay RA, Triche S, Sirockman B, DeLong MR (2002) Cognitive impairments in advanced PD without dementia. Neurology 59(9):1320–1324
6. Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 289(1–2):18–22. doi:10.1016/j.jns.2009.08.034
7. Hely MA, Morris JG, Reid WG, Trafficante R (2005) Sydney Multicenter Study of Parkinson’s disease: non-l-dopa-responsive problems dominate at 15 years. Mov Disord 20(2):190–199. doi:10.1002/mds.20324
8. Leroi I, McDonald K, Pantula H, Harbishettar V (2012) Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden. J Geriatr Psychiatry Neurol 25(4):208–214. doi:10.1177/0891988712464823
9. Pedersen KF, Larsen JP, Tysnes OB, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 70(5):580–586. doi:10.1001/jamaneurol.2013.2110
10. Carbon M, Marie RM (2003) Functional imaging of cognition in Parkinson’s disease. Curr Opin Neurol 16(4):475–480. doi:10.1097/01.wco.0000084225.82329.3c
11. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D (2007) Metabolic brain networks associated with cognitive function in Parkinson’s disease. Neuroimage 34(2):714–723. doi:10.1016/j.neuroimage.2006.09.003
12. Peraza LR, Colloby SJ, Firbank MJ, Greasy GS, McKeith IG, Kaiser M, O’Brien J, Taylor JP (2015) Resting state in Parkinson’s disease dementia and dementia with Lewy bodies: commonalities and differences. Int J Geriatr Psychiatry 30(11):1135–1146. doi:10.1002/gps.4342
13. Beyer MK, Janvin CC, Larsen JP, Aarsland D (2007) A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78(3):254–259. doi:10.1136/jnnp.2006.093849
14. Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH (2011) The pattern of cortical atrophy in patients with Parkinson’s disease according to cognitive status. Mov Disord 26(2):289–296. doi:10.1002/mds.23477
15. Mak E, Zhou J, Tan LC, Au WL, Sitoh YY, Kandiah N (2014) Cognitive deficits in mild Parkinson’s disease are associated with distinct areas of grey matter atrophy. J Neurol Neurosurg Psychiatry 85(5):576–580. doi:10.1136/jnnp-2013-305805
16. Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, Dagher A, Ito K (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64(2):224–229. doi:10.1212/01.wnl.0000149510.41793.50
17. Summerfield C, Junque C, Tolosa E, Salgado-Pineda P, Gomez-Anson B, Marti MJ, Pastor P, Ramirez-Ruiz B, Mercader J (2005) Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 62(2):281–285. doi:10.1001/archneur.62.2.281
18. Xia J, Miu J, Ding H, Wang X, Chen H, Wang J, Wu J, Zhao J, Huang H, Tian W (2013) Changes of brain gray matter structure in Parkinson’s disease patients with dementia. Neural Regen Res 8(14):1276–1285. doi:10.3969/j.issn.1673-5374.2013.14.004
19. Compta Y, Ibarretxe-Bilbao N, Pereira JB, Junque C, Bargallo N, Tolosa E, Valldeoriola F, Munoz E, Camara A, Buongiorno M, Marti MJ (2012) Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson’s disease and related dementia. Parkinsonism Relat Disord 18(8):941–947. doi:10.1016/j.parkreldis.2012.04.028
20. Lee SH, Kim SS, Tae WS, Lee SY, Lee KU, Jhoo J (2013) Brain volumetry in Parkinson’s disease with and without dementia: where are the differences? Acta Radiol 54(5):581–586. doi:10.1177/0284185113476029
21. Mak E, Su L, Williams GB, O’Brien JT (2015) Neuroimaging correlates of cognitive impairment and dementia in Parkinson’s disease. Parkinsonism Relat Disord 21(8):862–870. doi:10.1016/j.parkreldis.2015.05.013
22. Goldman JG, Stebbins GT, Dinh V, Bernard B, Merkitch D, deToledo-Morrell L, Goetz CG (2014) Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson’s disease with hallucinations. Brain 137(Pt 3):849–859. doi:10.1093/brain/awt360
23. Radua J, Mataix-Cols D, Phillips ML, El-Hage W, Kronhaus DM, Cardoner N, Surguladze S (2012) A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. Eur Psychiatry 27(8):605–611. doi:10.1016/j.eurpsy.2011.04.001
24. Radua J, Rubia K, Canales-Rodriguez EJ, Pomarol-Clotet E, Fusar-Poli P, Mataix-Cols D (2014) Anisotropic kernels for coordinate-based meta-analyses of neuroimaging studies. Front Psychiatry 5:13. doi:10.3389/fpsyt.2014.00013
25. Sheng L, Ma H, Zhong J, Shang H, Shi H, Pan P (2015) Motor and extra-motor gray matter atrophy in amyotrophic lateral sclerosis: quantitative meta-analyses of voxel-based morphometry studies. Neurobiol Aging 36(12):3288–3299. doi:10.1016/j.neurobiolaging.2015.08.018
26. Zhong J, Pan P, Dai Z, Shi H (2014) Voxelwise meta-analysis of gray matter abnormalities in dementia with Lewy bodies. Eur J Radiol 83(10):1870–1874. doi:10.1016/j.ejrad.2014.06.014
27. Pan PL, Shi HC, Zhong JG, Xiao PR, Shen Y, Wu LJ, Song YY, He GX, Li HL (2013) Gray matter atrophy in Parkinson’s disease with dementia: evidence from meta-analysis of voxel-based morphometry studies. Neurol Sci 34(5):613–619. doi:10.1007/s10072-012-1250-3
28. Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ (2012) Grey matter atrophy in cognitively impaired Parkinson’s disease. J Neurol Neurosurg Psychiatry 83(2):188–194. doi:10.1136/jnnp-2011-300828
29. Leff AP, Schofield TM, Crinion JT, Seghier ML, Grogan A, Green DW, Price CJ (2009) The left superior temporal gyrus is a shared substrate for auditory short-term memory and speech comprehension: evidence from 210 patients with stroke. Brain 132(Pt 12):3401–3410. doi:10.1093/brain/awp273
30. Bigler ED, Mortensen S, Neeley ES, Ozonoff S, Krasny L, Johnson M, Lu J, Provencal SL, McMahon W, Lainhart JE (2007) Superior temporal gyrus, language function, and autism. Dev Neuropsychol 31(2):217–238. doi:10.1080/87565640701190841
31. Phan KL, Wager T, Taylor SF, Liberzon I (2002) Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 16(2):331–348. doi:10.1006/nimg.2002.1087
32. Dupont S (2002) Investigating temporal pole function by functional imaging. Epileptic Disord Int Epilepsy J Videotape 4(Suppl 1):S17–S22
33. Henry JD, Crawford JR (2004) Verbal fluency deficits in Parkinson’s disease: a meta-analysis. J Int Neuropsychol Soc JINS 10(4):608–622. doi:10.1017/s1355617704104141
34. Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, Campdelacreu J, Gascon J, Falcon C, Calopa M, Jauma S, Juncadella M, Junque C (2009) Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson’s disease with dementia. Mov Disord 24(12):1740–1746. doi:10.1002/mds.22488
35. Braak H, Braak E (2000) Pathoanatomy of Parkinson’s disease. J Neurol 247(Suppl 2):ii3–ii10
36. Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease. Acta Neuropathol 100(3):285–290
37. Ibarretxe-Bilbao N, Junque C, Segura B, Baggio HC, Marti MJ, Valldeoriola F, Bargallo N, Tolosa E (2012) Progression of cortical thinning in early Parkinson’s disease. Mov Disord 27(14):1746–1753. doi:10.1002/mds.25240
38. Compta Y, Pereira JB, Rios J, Ibarretxe-Bilbao N, Junque C, Bargallo N, Camara A, Buongiorno M, Fernandez M, Pont-Sunyer C, Marti MJ (2013) Combined dementia-risk biomarkers in Parkinson’s disease: a prospective longitudinal study. Parkinsonism Relat Disord 19(8):717–724. doi:10.1016/j.parkreldis.2013.03.009
39. Greene SJ, Killiany RJ (2010) Subregions of the inferior parietal lobule are affected in the progression to Alzheimer’s disease. Neurobiol Aging 31(8):1304–1311. doi:10.1016/j.neurobiolaging.2010.04.026
40. Pennanen C, Testa C, Laakso MP, Hallikainen M, Helkala EL, Hanninen T, Kivipelto M, Kononen M, Nissinen A, Tervo S, Vanhanen M, Vanninen R, Frisoni GB, Soininen H (2005) A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 76(1):11–14. doi:10.1136/jnnp.2004.035600
41. Apostolova LG, Morra JH, Green AE, Hwang KS, Avedissian C, Woo E, Cummings JL, Toga AW, Jack CR Jr, Weiner MW, Thompson PM (2010) Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage 51(1):488–499. doi:10.1016/j.neuroimage.2009.12.125
42. Rousseaux MW, Marcogliese PC, Qu D, Hewitt SJ, Seang S, Kim RH, Slack RS, Schlossmacher MG, Lagace DC, Mak TW, Park DS (2012) Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease. Proc Natl Acad Sci USA 109(39):15918–15923. doi:10.1073/pnas.1205102109
43. Junque C, Ramirez-Ruiz B, Tolosa E, Summerfield C, Marti MJ, Pastor P, Gomez-Anson B, Mercader JM (2005) Amygdalar and hippocampal MRI volumetric reductions in Parkinson’s disease with dementia. Mov Disord 20(5):540–544. doi:10.1002/mds.20371
44. Apostolova LG, Beyer M, Green AE, Hwang KS, Morra JH, Chou YY, Avedissian C, Aarsland D, Janvin CC, Larsen JP, Cummings JL, Thompson PM (2010) Hippocampal, caudate, and ventricular changes in Parkinson’s disease with and without dementia. Mov Disord 25(6):687–695. doi:10.1002/mds.22799
45. Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, Tolosa E, Marti MJ (2013) Cortical thinning is associated with disease stages and dementia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 84(8):875–881. doi:10.1136/jnnp-2012-304126
46. Wang WY, Yu JT, Liu Y, Yin RH, Wang HF, Wang J, Tan L, Radua J, Tan L (2015) Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease. Transl Neurodegener 4:6. doi:10.1186/s40035-015-0027-z
47. Jellinger KA (2005) Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol 64(6):554
48. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW (2001) Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 71(4):441–447
49. Ramirez-Ruiz B, Marti MJ, Tolosa E, Bartres-Faz D, Summerfield C, Salgado-Pineda P, Gomez-Anson B, Junque C (2005) Longitudinal evaluation of cerebral morphological changes in Parkinson’s disease with and without dementia. J Neurol 252(11):1345–1352. doi:10.1007/s00415-005-0864-2
50. Ibarretxe-Bilbao N, Ramirez-Ruiz B, Tolosa E, Marti MJ, Valldeoriola F, Bargallo N, Junque C (2008) Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia. J Neurol 255(9):1324–1331. doi:10.1007/s00415-008-0885-8
51. Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127(Pt 4):791–800. doi:10.1093/brain/awh088
52. Ramirez-Ruiz B, Marti MJ, Tolosa E, Gimenez M, Bargallo N, Valldeoriola F, Junque C (2007) Cerebral atrophy in Parkinson’s disease patients with visual hallucinations. Eur J Neurol 14(7):750–756. doi:10.1111/j.1468-1331.2007.01768.x